News

PerkinElmer’s current CFO, Jeffrey Capello, is resigning to pursue another opportunity outside the company, effective June 6, 2008. Since Mr Battles joined PerkinElmer in 2001 as controller for

Physicians use the test information to monitor the effects of antiretroviral therapy by measuring changes in HIV-1 RNA levels. Roche’s newest HIV-1 viral load monitoring test is said

The cannula line includes reusable closed cannulas in three sizes (4.5mm, 5.0mm, 5.5mm), as well as a slotted cannula, which allows the surgeon to utilize larger and curved

The Pevion vaccine has successfully completed human clinical trial Phases I and II in Switzerland and in the UK, respectively, with only two of four contemplated antigens. The

The randomized, double-blinded, placebo-controlled trial, which is being conducted at over 10 sites across France, will enroll up to 36 patients in the intensive care setting who are

GSK’s pre-pandemic H5N1 vaccine is formulated with a novel proprietary adjuvant system, which is designed to achieve a high immune response at a low dose of antigen that

Lotus obtained the patent, along with exclusive production rights for Laevo-Bambutero in China, for a cash payment of RMB48 million and a 3% royalty on products sales. The

PSI-7851 is a proprietary nucleotide analogue polymerase inhibitor of hepatitis C virus (HCV) that is being advanced into good laboratory practice animal toxicity studies required for submission of

The preclinical trial was a six-month, single-arm study to evaluate the application of Tengion’s technology to regenerate an entire urinary bladder. Neo-Bladder Replacements were produced from autologous bladder